Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

NCT00193037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Liposomal Doxorubicin
DRUG: Docetaxel

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]